Greenwich LifeSciences Market Cap

Greenwich LifeSciences has a market cap or net worth of $182.74 million as of May 17, 2024. Its market cap has increased by 29.06% in one year.

Market Cap

182.74M

Enterprise Value

175.76M

1-Year Change

29.06%

Ranking

#3729

Market Cap Chart

Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $182.74M, an increase of 166.05%. That is a compound annual growth rate of 30.81%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	180.00M	-3.28%
May 16, 2024	186.10M	-2.05%
May 15, 2024	190.00M	8.14%
May 14, 2024	175.70M	4.46%
May 13, 2024	168.20M	-5.03%
May 10, 2024	177.10M	-1.83%
May 9, 2024	180.40M	2.50%
May 8, 2024	176.00M	0.28%
May 7, 2024	175.50M	-1.74%
May 6, 2024	178.60M	-3.62%
May 3, 2024	185.30M	2.83%
May 2, 2024	180.20M	-0.06%
May 1, 2024	180.30M	12.76%
Apr 30, 2024	159.90M	-1.48%
Apr 29, 2024	162.30M	-3.96%
Apr 26, 2024	169.00M	6.36%
Apr 25, 2024	158.90M	-2.22%
Apr 24, 2024	162.50M	-3.96%
Apr 23, 2024	169.20M	3.55%
Apr 22, 2024	163.40M	5.15%
Apr 19, 2024	155.40M	-6.39%
Apr 18, 2024	166.00M	-1.25%
Apr 17, 2024	168.10M	-9.48%
Apr 16, 2024	185.70M	1.14%
Apr 15, 2024	183.60M	-8.70%

View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Compugen	197.86M
Kodiak Sciences	196.44M
Inventiva	195.87M
Trevi Therapeutics	194.75M
YS Biopharma Co.	193.98M
Galectin Therapeutics	189.43M
Fennec Pharmaceuticals	189.16M
Genfit	188.42M

Market Cap Rankings